Acting CFO of Enzymatica appointed
March 24 2016 - 3:30AM
Bengt Jöndell has been appointed
Acting CFO of Enzymatica with effect from 4 April. Johan
Wennerholm, Enzymatica's current CFO, has decided to leave the
company to take up an appointment as CEO of a company outside the
Group. The recruitment process for a new CFO has begun. Johan
Wennerholm will remain with the company for the next few months to
facilitate the hand-over to Bengt Jöndell.
Bengt's most recent post was as CFO and
Administrative Manager at BTJ Group AB. Before that, his
appointments included Senior Financial Advisor at the med tech
company, BoneSupport, CFO/Administrative Manager at Inpac, Business
Controller at Pharmacia & Upjohn Consumer Healthcare, Pharmacia
Consumer Pharma and Kabi Pharmacia Nicorette.
"Bengt
Jöndell has an excellent background for an Acting CFO, with 25
years' experience of finance, HR, IT and
management from international companies, part of that in
pharmaceuticals," said Fredrik Lindberg, CEO of Enzymatica. Fredrik
continued:
"Johan
Wennerholm has done an outstanding job at Enzymatica, including
leading the listing process on Nasdaq First North. He has made a
highly significant contribution to the company's progress in areas
such as finance and administration. I wish him every success with
his new challenges."
For more information, please
contact:
Fredrik Lindberg, CEO, Enzymatica AB
Tel: 0708-86 53 70 | E-mail:
fredrik.lindberg@enzymatica.com
About Enzymatica AB
Enzymatica is a life science company who develops and sells medical
device products against infectious-related diseases. Over a short
period the company has developed a unique oral spray for colds,
ColdZyme®, and launched it on six markets. The product has become
one of the leading articles for colds in Swedish pharmacies.
Enzymatica's strategy is to continue growing by strengthening its
position in existing markets and to expand to more geographical
markets through well-established partners. The company is
headquartered in Lund, Sweden and is listed on Nasdaq First North.
For more information, please visit
www.enzymatica.com.
Enzymatica's certified adviser is Erik Penser
Bankaktiebolag.
Press Release (PDF)
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Enzymatica AB via Globenewswire
HUG#1997235
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2024 to Aug 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Aug 2023 to Aug 2024